RUNX2 and metastatic malignant neoplasm in the lymph nodes: Correlation analysis of Runx2 mRNA expression with TNM staging of PDAC patients revealed a tendency for decreased median Runx2 mRNA levels in PDAC patients with lymph node metastasis compared to PDAC patients without lymph node metastasis (P=0.7; data not shown).